Method for inhibiting osteoclast development
This invention provides a composition comprising Formula I, or salt thereof, wherein X is either chlorine or bromine, Y is either hydrogen or an alkyl group having a carbon chain length from 1 to 5 carbon atoms, and R is an alkyl group having a carbon chain length from 1 to 5 carbon atoms, except that X is not chlorine when Y is hydrogen and R is an ethyl group. A method of preventing bone erosion in a patient and a method of reducing inflammation in a patient using the compositions of Formula I are disclosed.
1. A method of inhibiting osteoclast development comprising:
administering an effective amount of a haloanilide composition or a salt thereof to an osteoclast cell for inhibiting osteoclast development, wherein said haloanilide composition is not N-(3,4-dichlorophenyl)propanamide, and wherein said haloanilide is a composition of Formula I, or salt thereof, comprising
wherein X is chlorine, wherein R is an ethyl group, and wherein Y is a methyl group.
2. A method for preventing bone erosion in a patient diagnosed with arthritis comprising:
administering to a patient an effective amount of a haloanilide composition or salt thereof for preventing bone erosion in a patient diagnosed with arthritis, wherein said haloanilide composition is not N-(3,4-dichlorophenyl)propanamide, and wherein said haloanilide is a composition of Formula I, or salt thereof, comprising
wherein X is chlorine, wherein R is an ethyl group and Y is a methyl group.